Zurich May 2016: AusBiotech, in an agreement with Biotechgate, launches the AusBiotech Australian Life Science Innovation Directory, a fully searchable database, offering vital information on the biotechnology and life science industry in Australia.
The stand-alone platform will be a welcome resource for the sector in Australia and also sees the Australian Directory join the 38,000-strong international company database on Biotechgate (biotechgate.com).
Members of AusBiotech have their own company profile, enabling them to better communicate and raise awareness of their own contribution to the biotechnology and life science field in Australia. In addition they will receive a special discount off the annual subscription to Biotechgate company and deals database.
Speaking about the launch of the AusBiotech directory, Patrik Frei, CEO of Venture Valuation said:
The launch of the Australian Life Sciences Innovation Directory by AusBiotech, in agreement with us, shows the extent and reach of Biotechgate not only in North America and Europe, but also in Asia Pacific.
AusBiotech’s Chief Executive Officer, Dr Anna Lavelle, expressed her delight at the launch, saying:
AusBiotech has supported the Directory in order to promote the growth and potential of the Australian biotechnology industry on a global scale.
The Biotechgate Database is the property of Venture Valuation AG, Switzerland. Biotechgate is a global life science database providing the user with information on life science companies, licensing products, financing rounds as well as key data on management structures and technology platforms. It also contains a database on licensing deals and associated financial information on individual deals.
AusBiotech joins a host of directories on the database from other jurisdictions, including: San Diego, Canada, France, Germany, Maryland and Sweden.
The Biotechgate Database is property of Venture Valuation AG, Switzerland. Biotechgate is a global Life Science Database containing over 38,000 company profiles and providing the user with information on life science companies, licensing products, financing rounds as well as key data on management structures and technology platforms. It also contains a database on licensing deals and associated financial information on individual deals.
Venture Valuation AG (www.venturevaluation.com)
Venture Valuation specializes in independent, third party assessment, valuation and monitoring of emerging life sciences companies (biotechnology, med-tech and pharma). Services are provided in the form of independent Valuation Reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Switzerland (Europe), Canada (North America) and Singapore (APAC), Venture Valuation has an experienced team of scientists and business professionals with expertise in finance, biotechnology, pharmaceutical and high technology industries.
For further information, please contact: Patrik Frei, CEO Venture Valuation, firstname.lastname@example.org | +41 43 321 8660